Bio-Rad (BIO) Shares Tumble as Credit Agricole Downgrades from Outperform to Underperform
Get Alerts BIO Hot Sheet
Price: $387.70 -0.57%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Shares of Bio-Rad Labs (NYSE: BIO) have sunk midday Tuesday following an intraday downgrade from Credit Agricole's Paul Knight. The stock is now down 0.8 percent to $102.25.
Knight now rates Bio-Rad shares an Underperform, down from Outperform previously. The analyst cut his price target on the stock from $110 to $108.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Knight now rates Bio-Rad shares an Underperform, down from Outperform previously. The analyst cut his price target on the stock from $110 to $108.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Zeon Corp (4205:JP) (ZEOOF) to Buy
- Axis Capital Limited Upgrades Blue Star Limited (BLSTR:IN) to Buy (1)
- Citi Upgrades Bapcor Ltd. (BAP:AU) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share